NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,088 filers reported holding NOVARTIS A G in Q3 2019. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $818,000 | -6.2% | 9,681 | -2.6% | 0.41% | +9.7% |
| Q1 2022 | $872,000 | +0.3% | 9,936 | 0.0% | 0.37% | +5.1% |
| Q4 2021 | $869,000 | +6.9% | 9,936 | 0.0% | 0.35% | -2.2% |
| Q3 2021 | $813,000 | -10.4% | 9,936 | 0.0% | 0.36% | -9.3% |
| Q2 2021 | $907,000 | +6.8% | 9,936 | 0.0% | 0.40% | +0.5% |
| Q1 2021 | $849,000 | -9.5% | 9,936 | 0.0% | 0.40% | -15.5% |
| Q4 2020 | $938,000 | +8.6% | 9,936 | 0.0% | 0.47% | -1.7% |
| Q3 2020 | $864,000 | -1.7% | 9,936 | -1.2% | 0.48% | -7.7% |
| Q2 2020 | $879,000 | +5.9% | 10,061 | 0.0% | 0.52% | -9.3% |
| Q1 2020 | $830,000 | -16.2% | 10,061 | -3.7% | 0.57% | +47.2% |
| Q4 2019 | $990,000 | +8.7% | 10,451 | -0.3% | 0.39% | +5.1% |
| Q3 2019 | $911,000 | -4.8% | 10,486 | 0.0% | 0.37% | -6.6% |
| Q2 2019 | $957,000 | – | 10,486 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |